Brief: Ardelyx Enters Commercial Supply Agreement With Catalent Pharma Solutions
Aug 12 (Reuters) - Ardelyx Inc ARDX.O :
* ARDELYX- ON AUG 7 ENTERED COMMERCIAL SUPPLY AGREEMENT WITH
CATALENT PHARMA SOLUTIONS, LLC
* ARDELYX - UNDER SUPPLY AGREEMENT CATALENT WILL PERFORM
TABLETING, TESTING, RELEASE & BULK PACKAGING OF IBSRELA(REG)
* ARDELYX - WILL PAY CATALENT AGREED UPON UNIT PRICES FOR
PRODUCT,
WHICH WILL BE ADJUSTED ON AN ANNUAL BASIS, FROM JAN 1, 2025
Source text for Eikon: ID:n0001628280-24-036749
Further company coverage: ARDX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ardelyx
See all newsArdelyx, Inc. reports results for the quarter ended June 30 - Earnings Summary
Ardelyx says Q2 product revenue at record high but IBSRELA revenue below expectations
Brief: Ardelyx Q2 Product Sales USD 118.129 Million
Ardelyx Q1 product revenue rises 38% on IBSRELA growth
Brief: Ardelyx Q1 Product Sales USD 93.373 Million